Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is OXCARBAZEPINE USP, with a corresponding US DMF Number 17988.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 28, 2018, and payment made on September 28, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II